| Cat. No. |
Product Name |
Information |
| PC-70010 |
NBD-11021
|
A small molecule, full antagonist of CD4 that blocks gp120-CD4 interaction. |
| PC-45129 |
Saquinavir mesylate
|
Apotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays. |
| PC-42047 |
YYA-021
|
A small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity. |
| PC-42549 |
Raltegravir potassium salt
|
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM. |
| PC-42548 |
Raltegravir
|
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM. |
| PC-45165 |
Darunavir ethanolate
|
A potent, selective HIV-1 protease inhibitor that is extremely potent against laboratory HIV-1 strains and primary clinical isolates with IC50 of 3 nM, IC90 of 9 nM. |
| PC-45164 |
Darunavir
|
A potent, selective HIV-1 protease inhibitor that is extremely potent against laboratory HIV-1 strains and primary clinical isolates with IC50 of 3 nM, IC90 of 9 nM. |
| PC-45473 |
(±)-BI-D
|
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase. |
| PC-45509 |
D77
|
A potent inhibitor of HIV-1 integrase-LEDGF/p75 interaction. |
| PC-42659 |
Delavirdine mesylate
|
A potent HIV-1 reverse transcriptase inhibitor with IC50 of 0.26 uM for recombinant HIV-1 RT. |
| PC-42658 |
Delavirdine
|
A potent HIV-1 reverse transcriptase inhibitor with IC50 of 0.26 uM for recombinant HIV-1 RT. |
| PC-45253 |
Amprenavir
|
A potent HIV-1 protease inhibitor with IC50 of 80 nM, has mean IC50 of 12 nM against 6 HIV clinical isolates. |
